Commented Articles

PanNASH covers commented articles ans publications to acquire sufficient information, understanding, and skills to cope with NASH/NAFLD healthcare demands.

From NAFLD/NASH to HCC: role of mitochondrial defects

This review by M. Longo et al. (IRCCS – Università degli Studi di Milano, Italy) discusses how mitochondrial defects may be translated into causative explanations of NAFLD-driven hepatocellular carcinoma. Acting as central metabolic hubs, the mitochondria rapidly adapt to different metabolic alterations...
Read MoreFrom NAFLD/NASH to HCC: role of mitochondrial defects

Obesity and liver cancer in Japan

It is estimated that there are more than 10 million NAFLD patients in Japan. 10-20% of NASH patients will progress to liver cirrhosis and 2-3% of them will develop hepatocellular carcinoma per year. In their review, H. Nishikawa et al. (Osaka Medical and Pharmaceutical University, Takatsuki, and Hyogo College of Medicine, Japan) comprehensively...
Read MoreObesity and liver cancer in Japan

Increasing prevalence of NAFLD/NASH among children, adolescents, and young adults

X. Zhang et al. (Fudan University, Shanghai, China) collected, from the Global Burden of Disease database, annual cases, and prevalence of NAFLD/NASH from 1990 to 2017, by sex, region and country. This study shows that both the prevalence and number of cases of NAFLD/NASH have...
Read MoreIncreasing prevalence of NAFLD/NASH among children, adolescents, and young adults

NAFLD/NASH-related liver fibrosis: mechanisms, treatment, and prevention

NAFLD or NASH are nowadays the leading causes of hepatic fibrosis worldwide. In their review, F. Tacke (Charité University Medicine, Berlin, Germany) and R. Weiskirchen (RWTH University Hospital, Aachen, Germany) discuss recent advances in antifibrotic prevention and therapy....
Read MoreNAFLD/NASH-related liver fibrosis: mechanisms, treatment, and prevention

NASH-NAFLD: clinical impact of sexual dimorphism

NAFLD/NASH is a sex dimorphic disease, with a general higher prevalence in men. Women are at reduced risk of NAFLD compared to men in fertile age. Sexual category, sex hormones and gender habits interact with numerous NAFLD factors including cytokines, stress, and environmental factors and alter the risk profiles and phenotypes of NAFLD...
Read MoreNASH-NAFLD: clinical impact of sexual dimorphism

Assessment of imaging modalities against liver biopsy

Multiparametric MRI is a promising technique to assess hepatic steatosis, inflammation, and fibrosis, potentially enabling non-invasive identification of individuals with active and advanced stages of NAFLD. The aim of the current proof-of-principle study by M. A. Troelstra et al. (Amsterdam University Medical Centres, The ...
Read MoreAssessment of imaging modalities against liver biopsy

Immunotherapy-treated HCC: NASH limits anti-tumour surveillance

Immunotherapy has been approved for treating hepatocellular carcinoma (HCC), but biomarker-based stratification of patients for optimal response to therapy is an unmet need. In preclinical models of NASH-induced HCC, therapeutic immunotherapy targeted at programmed death-1 (PD1) did not lead...
Read MoreImmunotherapy-treated HCC: NASH limits anti-tumour surveillance

Rising awareness on NAFLD progression by influencing threat perceptions

It is estimated that around 70% of Type 2 Diabetes Mellitus patients (T2DM) have NAFLD. Awareness and education are major shortcomings of the public health response to the increasing threat of NAFLD. Characterising the specific NAFLD-related information needs of particular high-risk metabolic communities might aid in the development of...
Read MoreRising awareness on NAFLD progression by influencing threat perceptions

NAFLD and risk factors: accuracy and limitations of the ICD-10-Australian Modification

Understanding the limitations of International Classification of Diseases (ICD) codes is important to improve the reliability of health system databases for epidemiological studies and health services research. KL Hayward et al. conducted a retrospective audit to explore the accuracy and limitations of the ICD-10-Australian Modification...
Read MoreNAFLD and risk factors: accuracy and limitations of the ICD-10-Australian Modification